Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy

Hypertension - United States
doi 10.1161/01.hyp.0000060689.38912.cb
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.

BMJ
1992English

Beneficial Effects of Angiotensin Converting Enzyme Inhibition on Renal Function in Patients With Diabetic Nephropathy.

BMJ
1986English

Angiotensin-I Converting Enzyme Polymorphism and Diabetic Nephropathy in North India

International Journal of Human Genetics
Genetics
2005English

Polymorphism of Angiotensin-Converting Enzyme (Rs4340) and Diabetic Nephropathy in Caucasians With Type 2 Diabetes Mellitus

Balkan Journal of Medical Genetics
Genetics
2016English

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2009English

Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury

American Journal of Pathology
Forensic MedicinePathology
2007English

Review: Angiotensin-Converting Enzyme Inhibitors Reduce the Progression of Non-Diabetic Renal Disease

Evidence-Based Medicine
Medicine
2002English

Murine Recombinant Angiotensin-Converting Enzyme 2: Effect on Angiotensin II-Dependent Hypertension and Distinctive Angiotensin-Converting Enzyme 2 Inhibitor Characteristics on Rodent and Human Angiotensin-Converting Enzyme 2

Hypertension
Internal Medicine
2012English

Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients With Diabetes

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy